CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/13/21
CASI Pharmaceuticals Partner, BioInvent, To Present Further Positive Clinical Data On BI-1206 At ASH 2021PRNewsWire • 11/05/21
CASI Pharmaceuticals To Report Third Quarter 2021 Financial Results And Host Conference Call November 12, 2021PRNewsWire • 11/02/21
CASI Pharmaceuticals, Inc. (CASI) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 11/01/21
CASI Pharmaceuticals Announces Partner Juventas Completion Of Series C Financing Of $63 Million (RMB410 Million) For Acceleration Of CNCT19 Pivotal Trials And CommercializationPRNewsWire • 10/25/21
CASI Pharmaceuticals, Inc. To Participate In Oppenheimer Fall Healthcare Life Sciences & MedTech SummitPRNewsWire • 09/20/21
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/13/21
CASI Pharmaceuticals To Report Second Quarter 2021 Financial Results And Host Conference Call August 12, 2021PRNewsWire • 08/10/21
Analysts Estimate CASI Pharmaceuticals, Inc. (CASI) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 08/02/21
CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple MyelomaPRNewsWire • 06/10/21
CASI Pharmaceuticals, Inc. To Participate In Jefferies Virtual Healthcare ConferencePRNewsWire • 05/27/21
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/19/21
CASI Pharmaceuticals To Report First Quarter 2021 Financial Results And Host Conference Call May 13, 2021PRNewsWire • 05/11/21